Masarone, D.; Valente, F.; Verrengia, M.; Contaldi, C.; di Palma, V.; Falco, L.; Catapano, D.; di Lorenzo, E.
Pharmacologic Treatment of Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction: Are There More Arrows on Our Bow? J. Clin. Med. 2024, 13, 6867.
https://doi.org/10.3390/jcm13226867
AMA Style
Masarone D, Valente F, Verrengia M, Contaldi C, di Palma V, Falco L, Catapano D, di Lorenzo E.
Pharmacologic Treatment of Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction: Are There More Arrows on Our Bow? Journal of Clinical Medicine. 2024; 13(22):6867.
https://doi.org/10.3390/jcm13226867
Chicago/Turabian Style
Masarone, Daniele, Fabio Valente, Marina Verrengia, Carla Contaldi, Vito di Palma, Luigi Falco, Dario Catapano, and Emilio di Lorenzo.
2024. "Pharmacologic Treatment of Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction: Are There More Arrows on Our Bow?" Journal of Clinical Medicine 13, no. 22: 6867.
https://doi.org/10.3390/jcm13226867
APA Style
Masarone, D., Valente, F., Verrengia, M., Contaldi, C., di Palma, V., Falco, L., Catapano, D., & di Lorenzo, E.
(2024). Pharmacologic Treatment of Pulmonary Hypertension Due to Heart Failure with Preserved Ejection Fraction: Are There More Arrows on Our Bow? Journal of Clinical Medicine, 13(22), 6867.
https://doi.org/10.3390/jcm13226867
